Browsing by Subject "A61P 1/00"

Now showing items 1-4 of 4

    • Compositions, methods and uses for a novel family of peptides 
      Jiang, Yi Wei (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2009-03-03)
      The present invention includes compositions and methods for the characterization and use of novel peptide from Brevibacillus sp., and peptides related thereto, including an isolated and purified, heat stable, amino ...
    • Control of microbial populations in the gastrointestinal tract of animals 
      Mckenzie, Scott K.; Giletto, Anthony; Hitchens, Duncan G.; Hargis, Billy M.; Herron, Kelly L. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2003-02-11)
      The present invention provides a method for controlling microbial populations in the gastrointestinal tract of animals. The method comprises the step of orally administering an effective amount of a peracid to an animal. ...
    • Glycyrrhetinic acid derivatives 
      Safe, Stephen H.; Chintharlapalli, Sudhakar; Mcalees, Alan; Mccrindle, Robert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-03-05)
      The present invention relates to novel derivatives of glycyrrhetinic acid, compositions comprising said derivatives and their use in the treatment of conditions or diseases that benefit from an upregulation of PPAR&ggr ...
    • Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative 
      Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.